LWANC
SNY icon

Laurel Wealth Advisors (North Carolina)’s Sanofi SNY Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,108
Closed -$63.9K – 765
2024
Q3 		$63.9K Hold
1,108
– – 0.01% 287
2024
Q2 		$53.8K Hold
1,108
– – 0.01% 283
2024
Q1 		$53.8K Hold
1,108
– – 0.01% 286
2023
Q4 		$55.1K Hold
1,108
– – 0.01% 272
2023
Q3 		$59.4K Hold
1,108
– – 0.01% 263
2023
Q2 		$59.7K Sell
1,108
-447
-29% -$24.1K 0.01% 270
2023
Q1 		$84.6K Buy
+1,555
New +$75.6K 0.02% 240

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Laurel Wealth Advisors (North Carolina)'s SNY Position: Q4 2024 in Review

Laurel Wealth Advisors (North Carolina) sold out of Sanofi (SNY) in Q4 2024, closing a stake of 1,108 shares — an estimated $63.9K sold.

Laurel Wealth Advisors (North Carolina) first reported a position in SNY in Q1 2023 and held it in 7 quarters. The position peaked at $84.6K in Q1 2023. 730 funds tracked by Wall St. Rank hold SNY as of Q4 2024.

  • Laurel Wealth Advisors (North Carolina) reported no remaining Sanofi position as of Q4 2024 after selling out during the quarter.
  • Laurel Wealth Advisors (North Carolina) sold 1,108 Sanofi shares in Q4 2024, an estimated $63.9K.
  • Laurel Wealth Advisors (North Carolina) first reported a position in Sanofi in Q1 2023 and held it in 7 quarters.
  • Laurel Wealth Advisors (North Carolina)'s Sanofi position peaked at $84.6K in Q1 2023.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q4 2024.

Based on Laurel Wealth Advisors (North Carolina)'s 13F filing for Q4 2024, filed 14 Jan 2025.